Overview
Hideyuki Takahashi practices practicing medicine in Maebashi, Japan.
Takahashi is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Spinocerebellar Ataxia Type 14, and Meningococcemia.
They are actively involved in clinical research, co-authoring 296 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hideyuki Takahashi
Is Hideyuki Takahashi a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Hideyuki Takahashi is classified as an Elite expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hideyuki Takahashi participate in research or clinical trials?
Yes. Hideyuki Takahashi has published 296 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Hideyuki Takahashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Oral Squamous Cell CarcinomaTakahashi isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Advanced
- Bacterial MeningitisTakahashi isAdvanced. Learn about Bacterial Meningitis.
- Cerebral HypoxiaTakahashi isAdvanced. Learn about Cerebral Hypoxia.
- MeningococcemiaTakahashi isAdvanced. Learn about Meningococcemia.
- Spinocerebellar Ataxia Type 14Takahashi isAdvanced. Learn about Spinocerebellar Ataxia Type 14.
- UrethritisTakahashi isAdvanced. Learn about Urethritis.
- Experienced
- Acute PainTakahashi isExperienced. Learn about Acute Pain.
- Anal CancerTakahashi isExperienced. Learn about Anal Cancer.
- Antisocial Personality DisorderTakahashi isExperienced. Learn about Antisocial Personality Disorder.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- DehydrationTakahashi isExperienced. Learn about Dehydration.
- GonorrheaTakahashi isExperienced. Learn about Gonorrhea.
- Hemolytic Transfusion ReactionTakahashi isExperienced. Learn about Hemolytic Transfusion Reaction.
- Infectious ArthritisTakahashi isExperienced. Learn about Infectious Arthritis.
- MeningitisTakahashi isExperienced. Learn about Meningitis.
- Muscle AtrophyTakahashi isExperienced. Learn about Muscle Atrophy.
- Nasal PolypsTakahashi isExperienced. Learn about Nasal Polyps.
- Olivopontocerebellar AtrophyTakahashi isExperienced. Learn about Olivopontocerebellar Atrophy.
- PIK3CA-Related Overgrowth SpectrumTakahashi isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Reactive ArthritisTakahashi isExperienced. Learn about Reactive Arthritis.
- SepsisTakahashi isExperienced. Learn about Sepsis.
- Septic ArthritisTakahashi isExperienced. Learn about Septic Arthritis.
- SinusitisTakahashi isExperienced. Learn about Sinusitis.
- Spinocerebellar AtaxiaTakahashi isExperienced. Learn about Spinocerebellar Ataxia.
- Spinocerebellar Ataxia Type 4Takahashi isExperienced. Learn about Spinocerebellar Ataxia Type 4.
- Spinocerebellar Ataxia Type 5Takahashi isExperienced. Learn about Spinocerebellar Ataxia Type 5.